Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-08 · accession 0001209191-22-017591 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2022-03-09 | 2021-03-09 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 80.0K | New | $0 |
| D | 2022-03-09 | 2022-03-08 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $1.37 | +20.0K | 47.0K | +74% | +$27.4K |
| D | 2022-03-09 | 2022-03-08 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 220.6K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-03-09 | G | D | 40,000 | $0.00 | 147,915 | I See footnote | — | — | (F2) The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |
| 2 | Common | Common Stock | 2021-03-09 | G | A | 40,000 | $0.00 | 80,000 | I | — | — | |
| 3 | Common | Common Stock | 2022-03-08 | M | A | 20,000 | $1.37 | 46,970 | D See footnote | — | — | (F1) The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. |
| 4 | Derivative | Stock Option (right to buy) | 2022-03-08 | M | D | 20,000 | $0.00 | 220,644 | D | $1.37 · — to 2026-11-15 | 20,000 Common Stock | (F4) The shares subject to the option are fully vested and immediately exercisable. |